U.S. FOOD AND DRUG ADMINISTRATION: CELLDYN Emerald Class 2 Device Recall
Class 2 Device Recall CELLDYN Emerald
Class 2 Device Recall CELLDYN Emerald
Class 2 Device Recall PalTop
SILVER SPRING, Md. -- The Food and Drug Administration (FDA) wants to overhaul the current clinical trial process by giving patients, doctors and researchers clearer access to clinical trial information, according to a new FDA statement released by former FDA Commissioner Dr. Scott Gottleib, current FDA director of the Center for Devices and Radiological Health, Dr. Jeff Shuren, and current chief of staff to the FDA commissioner, Lauren Silvis.
This month the U.S. Food and Drug Administration took the final steps in clearing the first family-planning app approved for use in the U.S.
Class 2 Device Recall FilterFlow Suction Handle
Class 2 Device Recall Nelaton Urinary Catheter
The U.S. Food and Drug Administration approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.
Class 2 Device Recall Gentrix Surgical Matrix Thick
An Israeli company is still working to get a medical device it says treats and potentially cures Alzheimer’s disease to be approved for use in the United States.